跳至主要内容
临床试验/NCT03786562
NCT03786562Unknown不适用

The Effect of Intravenous Nalbuphine on Postoperative Nausea and Vomiting With Intrathecal Morphine in Abdominoplastic Surgery.

Assiut University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年3月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
postoperative nausea and vomiting

研究概览

简要总结

How effectively intravenous nalbuphine can reduce the incidence of PONV after intrathecal administration of morphine in abdominoplastic surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients undergoing abdominoplasty under spinal anesthesia
  • American Society of Anesthesiologists (ASA) class I and II.

排除标准

  • allergy to local anesthetics
  • bleeding diatheses
  • local infection or sepsis

研究组 & 干预措施

Placebo group

Placebo Comparator

干预措施: Intrathecal Morphine (Drug)

Nalbuphine group

Active Comparator

干预措施: Intrathecal Morphine + Intravenous Nalbuphine (Drug)

结局指标

主要结局

postoperative nausea and vomiting

时间窗: 24 hours

A verbal descriptive scale (VDS) was used to assess the severity of PONV. ( no nausea=0, severe nausea= 10) by postoperative nausea and vomiting scale which range (o no nasuea to 10 sever vomating). A verbal descriptive scale (VDS) was used to assess the severity of PONV .

次要结局

  • postoperative pain and puririts.(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eman A. Ismail

Clinical Professor

Assiut University

研究点 (1)

Loading locations...

相似试验